SynBioBeta Biopharma Day

Ester Falconer, Ph.D., Chief Technology Officer, will be participating in a panel discussion on ‘The Promise of Antibody Treatments Across Disease States‘ at SynBioBeta’s first ever BioPharma Day.

PEGS Boston Virtual

Bo Barnhart, Ph.D., will be presenting will be presenting “Combating COVID-19: Identifying a Potential Drug Candidate for Human Testing in 90 Days” at PEGS Boston Virtual.

For more information on AbCellera’s response to COVID-19, click here.

Providence Health Care Innovation Seminar

Bo Barnhart, Ph.D. will be presenting Combating COVID-19: Identifying a Potential Drug Candidate for Human Testing in 90 Days at Providence Health Care’s Innovation Seminar Series.

Molecular Med Tri-Con Virtual

Bo Barnhart, Ph.D. will be presenting “From Patient Sample to Antibody Lead in Three Weeks: A Real-Time Response to COVID-19″ at the Molecular Med Tri-Con in the COVID-19 Vaccines & Biotherapeutics track.

For more information on AbCellera’s response to COVID-19, click here.

Discovery to Commercialization

Organized by UBC Faculty of Medicine and Vancouver Coastal Health Research Institute, Discovery to Commercialization is a series of education and networking events that aim to raise awareness and knowledge around the therapeutic commercialization process. Lucas Kraft will be representing AbCellera and presenting at the session ‘Building Bridges: How Researchers Came Together During COVID-19’.